behavior disorders in children

Size: px
Start display at page:

Download "behavior disorders in children"

Transcription

1 behavior disorders in children NHUNG T. TRAN, MD, FAAP DEVELOPMENTAL-BEHAVIORAL PEDIATRICS SCOTT & WHITE HEALTHCARE ASSOCIATE PROFESSOR TEXAS A&M HEALTH SCIENCE CENTER COLLEGE OF MEDICINE MARCH 23, 2013 SCOTT & WHITE 22 ND ANNUAL ROBERT E. MYERS, MD, LECTURESHIP IN PEDIATRICS

2 faculty disclosure Discussion will reference some pharmaceuticals that are not approved by the FDA for use in children and adolescents. I have no relevant financial relationships with the manufacturer(s) of any commercial product(s) and/or provider of commercial services discussed in this CME activity.

3 objectives To better recognize typical from atypical behaviors To know behavioral screening tools and how they can be used in clinical practice To understand the management of some behavioral disorders

4 the whole child HPI: severely hyperactive, impulsive, aggressive, not learning FHX: maternal grandmother is alcohol-dependent drinker; mother is at-risk drinker and has mild ID Prenatal HX: daily binge drinking until 5 months gestation, in an effort to abort mary

5 the whole child Features Partial FAS Phenotype Developmental Behavioral Medical Intellectual Disability, Language Disorder ADHD, ODD, insomnia Growth 10 th percentile Motor Psychosocial Fine motor deficits, dysgraphia Poor social cognition, parentchild conflicts

6 the whole child Treatment Partial FAS Phenotype Developmental Behavioral Medical Special Education under OHI, MR and SI ; ST Medications, counseling Close monitoring Motor Psychosocial OT (school) Social skills training; maternal mental health; case management

7 extrinsic and intrinsic factors Maternal depression Parental attitude Parenting stress Parent characteristics Parenting style Behavior problem Child characteristics Poverty Social network Maternal education Socio- Economic Temperament Medical disability Cognitive disability Behavior disorder

8 behavior disorders in children Why did he do that? Should I be worried? What is going on? What should I do?

9 why did he do that? A-B-C S OF BEHAVIORS

10 taking the behavioral history in the eyes of the beholder misery loves company

11 why did he do that? result in self-injury, injury to others, cause damage to the physical environment and/or interfere with the acquisition of new skills, and/or socially isolate the learner [Doss & Reichle, 1991] Described by Form Function Social motivation

12 why did he do that? Form Single form per episode Sequence or group of behaviors per episode Function To communicate, especially emotion To avoid or escape undesired/nonpreferred outcomes (attention, objects, activities) To gain access to desired/preferred outcomes (attention, objects, activities)

13 why did he do that? Social motivation - what is needed to affect the probability that behaviors will continue to occur in the future Socially motivated: requires others in the environment Non-socially motivated: does not require others in the environment, often to gain access to or avoid/escape internal stimuli

14 why did he do that? Ex. Ben with quadriplegic CP and severe dysarthria slaps himself in the face until the teacher takes him to the playground Form: self-injury Function: gain access to desired activity (i.e., play) Socially mediated: teacher positively reinforces the inappropriate behavior

15 why did he do that? Ex. Noah likes to bang objects to make loud noises Form: making loud noises (disruptive) Function: gain access to desired outcome (sensory) Non-socially motivated: sensory stimulation positively reinforces the inappropriate behavior

16 why did he do that? Ex. Beth bangs her head with an ear infection. Mom picks up to soothe, offers toys, goes to the doctor. Now Beth bangs her head often. Form: self-injury Function: gain access to desired outcome (mom s attention) Non-socially motivated: decreased pain positively reinforces inappropriate behaviors Socially motivated: mom s attention further positively reinforces behavior

17 why did he do that? Ex. Kristin tantrums each time the teacher begins to work with her classmates Form: tantrums Function: gain desired outcome (i.e., teacher attention) Q: What would positively reinforce this behavior? Q: What would negatively reinforce this behavior?

18 why did he do that? Antecedents Setting events (context)? Antecedent stimulus (trigger)? Behaviors Response to stimulus? Consequences Maintaining consequence (reinforcers)?

19 should I be worried? TYPICAL VERSUS ATYPICAL SCREENING

20 should I be worried? When it s too odd, too often, too much Hyperactivity-impulsivity Anxiety Obsessive-compulsive behaviors Mood problems Aggression (verbal and physical) Self-injury

21 should I be worried? first stage screening second stage screening Brief Infant-Toddler Social & Emotional Assessment (BITSEA) Ages & Stages: Social-Emotional (ASQ:SE) Pediatric Symptom Checklist (PSC) Eyberg Child Behavior Inventory (ECBI) Pediatric Intake Form (a.k.a., Family Psychosocial Screen)

22 Pediatric Symptom Checklist General psychosocial screen [Jellinek, MD; Murphy, EdD] Ages 4-16 years Parent & self report (>9 years old) 35 items 7 minutes English, Spanish and many others Provides cut-off (including Attention, Internalizing, Externalizing subscales) Sensitivity 80-95%; specificity % px

23 should I be worried? When it s not within normal limits first stage screening second stage screening

24 should I be worried? first stage screening second stage screening Child Behavior Checklists (CBCL, TRF, C-TRF, YRF) Behavior Assessment Scale for Children, Second Edition (BASC-2) Infant-Toddler Social & Emotional Assessment (ITSEA)

25 what is going on? EVALUATION

26 what is going on? Appropriate referral for evaluation Evaluation consists of History Key clinical questions Clinical interview or observation Standardized questionnaires Differential diagnosis DSM-IV-TR criteria

27 standardized questionnaires ADHD: NICHQ Vanderbilt Assessment Scale Conners, 3 rd Edition (Conners 3) ADD-H Comprehensive Teacher s Rating Scale (ACTeRS), Second Edition Others: See attachment from Massachusetts General Hospital ools_table.asp

28 what should I do? MANAGEMENT

29 multimodal management Developmental assessment/supports Environmental assessment/supports Functional behavioral analysis Parenting skills Educational supports Behavioral and other therapies Psychopharmacotherapy

30 specific disorders ADHD ODD ANXIETY DISORDERS MOOD DISORDERS

31 ADHD overview signs & symptoms differential diagnosis diagnosis management pearls & pitfalls 4-6% prevalence Higher in lower SES Male:female estimated at 2:1 Etiology Genetic factors Medical risk factors Prognosis Symptoms persists into adulthood, but change over time Better if treated, no co-morbid behavior disorders, higher IQ, higher SES

32 ADHD overview signs & symptoms differential diagnosis diagnosis management pearls & pitfalls Presentation: ADHD-IA: academic problems ADHD-HI: conduct problems ADHD-CT: both 3-5 years 6-8 years ADHD-CT, -HI ADHD-IA severe mild home school social +/- safety +/-

33 ADHD overview signs & symptoms differential diagnosis diagnosis management pearls & pitfalls Clinical observation* Physical examination* Diagnosis is by DSM-IV-TR criteria Other studies if indicated: Psychoeducational if learning disability suspected Neurological (e.g., EEG) if neurological condition suspected * Often not helpful

34 ADHD overview signs & symptoms differential diagnosis diagnosis management pearls & pitfalls Pharmacologic mainstay Stimulants Atomoxetine Alpha-agonist Certain atypical antidepressants Guidelines Texas Children s Medication Algorithm Project [Pliszka et al, 2006] Psychopharmacological Treatment for Very Young Children [Gleason et al, 2007]

35 Pliszka et al, JAACAP, 2006, 45(6): 642

36 Pliszka et al, JAACAP, 2006, 45(6): 642

37 ADHD medication guide

38 ADHD overview signs & symptoms differential diagnosis diagnosis management pearls & pitfalls Non-pharmacologic Parenting (or parent training) especially in preschool aged children Psychotherapy if co-morbidity Complementary & alternative Refer if Not responsive to medications Persistent, unacceptable side effects Diagnosis is not clear

39 ADHD overview signs & symptoms differential diagnosis diagnosis management pearls & pitfalls Diagnostic certainty is impossible Co-morbidities are common Myths and misconceptions are common Goal is reducing morbidities (home, school, social, safety) Be familiar with the pharmacokinetics Care coordination improves prognosis

40 ODD overview signs & symptoms differential diagnosis diagnosis management pearls & pitfalls Recurrent pattern of negativistic, disobedient, hostile behaviors 2-16% prevalence Higher in males Etiology Genetic factors (slight) Environmental factors (significant) Temperamental factors (significant) Co-morbidities Behavioral: ADHD, mood, conduct Developmental: language disorders

41 ODD overview signs & symptoms differential diagnosis diagnosis management pearls & pitfalls Presentation Onset<3 years old, increases with age Worse in>out of the home Symptoms Tantrums Persistent stubbornness Resistance to directions Inflexibility Deliberate, persistent testing of limits Verbal>physical aggression Labile mood Low frustration tolerance Low self-image

42 ODD overview signs & symptoms differential diagnosis diagnosis management pearls & pitfalls Clinical observation (in vitro)* Physical examination* Diagnosis is by DSM-IV-TR criteria Other studies if indicated: Speech-language if speech-language disorder suspected Psychoeducational if developmental or learning disability suspected * Often not helpful

43 ODD overview signs & symptoms differential diagnosis diagnosis management pearls & pitfalls Advice on behaviors* Rather, focus on other anticipatory issues (e.g., exposure to violence) Counseling mainstay Psychologist Licensed professional counselor Goal is to reduce symptoms Parenting (or parent training) Family therapy Cognitive-behavioral therapy Collaborative problem solving (Pharmacologic) * Often not helpful

44 anxiety disorders overview signs & symptoms differential diagnosis diagnosis management pearls & pitfalls 13% prevalence Most common psychiatric disorder 33% have 2 other anxiety disorders Etiology: Genetic factors Environmental factors Temperamental factors Prognosis: Often chronic, persistent into adulthood

45 anxiety disorders overview signs & symptoms differential diagnosis diagnosis management pearls & pitfalls Types: Simple phobia (10-11%) Generalized anxiety disorder (3-10%) Obsessive compulsive disorder (2.5%) Separation anxiety disorder (4%) Social phobia (10-11%) Generalized versus non-generalized Selective mutism Posttraumatic stress disorder (1-14%) Panic disorder ( %)

46 anxiety disorders overview signs & symptoms differential diagnosis diagnosis management pearls & pitfalls Presentation: Cognitive catastrophic thoughts, poor school performance Physical nausea, pain, headaches, eating problems, sleeping problems Emotional fears, worry Behavioral avoidance, escape, emotional outbursts Ask about Duration, frequency, intensity Anticipatory vigilance?

47 anxiety disorders overview signs & symptoms differential diagnosis diagnosis management pearls & pitfalls DDX: Developmentally appropriate worries and fears Medical conditions (due to somatic complaints) Medication side effects Learning d/o (e.g., school refusals) Developmental d/o (resulting in younger mental age)

48 anxiety disorders overview signs & symptoms differential diagnosis diagnosis management History Clinical observation* Physical examination* DSM-IV-TR criteria Other studies if indicated: Medical evaluations to rule-out medical condition pearls & pitfalls * Often not helpful

49 anxiety disorders overview signs & symptoms differential diagnosis diagnosis management pearls & pitfalls Non-pharmacologic mainstay Parenting (or parent training), for children <8 years old Cognitive-behavioral therapy, for children >8 years old Pharmacologic When severe impairment in functioning Options: SSRI, atypical antidepressants, (benzodiazepines) Educational Supports Special Education under Emotional Disturbance

50 anxiety disorders overview signs & symptoms differential diagnosis Internalizing disorders are easier to under-recognize Often co-morbid externalizing disorders Have more contextual clues diagnosis management pearls & pitfalls

51 depressive disorders overview signs & symptoms differential diagnosis diagnosis management pearls & pitfalls 1-8% prevalence Etiology/risk factors: Genetic Environmental Neurodevelopmental factors/stages Medical 60-80% co-morbidities Types: Major Depressive Disorder Dysthymic Disorder

52 depressive disorders overview signs & symptoms differential diagnosis diagnosis management pearls & pitfalls Depressive episode: 2 weeks of 5 symptoms of: *Depressed mood *Markedly diminished interest or pleasure Significant weight loss or gain, or decrease or increase in appetite Insomnia or hypersomnia Psychomotor agitation or retardation Fatigue or loss of energy Feelings of worthlessness or excessive or inappropriate guilt Diminished ability to think or concentrate, or indecisiveness Recurrent thoughts of death, recurrent suicidal ideation, or suicide attempt

53 depressive disorders overview signs & symptoms differential diagnosis diagnosis management pearls & pitfalls Presentation: Infants/toddlers passive & unresponsive to irritable & inconsolable School aged irritability, withdrawn, somatic, morbid preoccupation Adolescents intense negative feelings, leading to irritability, anger, resentment, and self-harm DDX: Medical conditions Substances

54 depressive disorders overview signs & symptoms differential diagnosis diagnosis management pearls & pitfalls History Direct, private discussion with children and adolescents Clinical observation Physical examination* DSM-IV-TR criteria Other studies if indicated: Medical evaluations to rule-out medical conditions, substances * Often not helpful

55 depressive disorders overview signs & symptoms differential diagnosis diagnosis management pearls & pitfalls Setting Primary care provider for mildmoderate depression Mental health professionals for moderate-severe depression Immediate psychiatric evaluation if suicidal, psychotic, abusing substances Non-pharmacologic mainstay Counseling Psychosocial interventions Pharmacologic SSRI, (TCA)

56 bipolar disorder overview signs & symptoms differential diagnosis diagnosis management pearls & pitfalls True prevalence unknown Etiology/risk factors: Genetic Neurodevelopmental factors/stages Environmental 60-80% co-morbidities ADHD, conduct disorder, anxiety, substance abuse Prognosis Typically chronic, lifelong Often partial recovery, frequent relapse

57 bipolar disorder overview signs & symptoms differential diagnosis diagnosis management pearls & pitfalls Manic episode: 1 week of 3 symptoms of Abnormal mood: euphoria + irritability (extreme, persistent, threatening, out-ofcontrol, rages) Distractibility Increased activity/energy Grandiosity Flight of ideas Activities with bad outcome Sleep decreased Talkativeness Can be Mixed, Hypomanic episodes

58 bipolar disorder overview signs & symptoms History Clinical observation Physical examination* DSM-IV-TR criteria differential diagnosis diagnosis management pearls & pitfalls * Often not helpful

59 bipolar disorder overview signs & symptoms differential diagnosis diagnosis management pearls & pitfalls Goal: Control mania (and depression) Develop insight Adhere to medications, prevent relapse Address co-morbidities Pharmacologic mainstay Mood-stabilizers Combined treatments typically needed Non-pharmacologic Counseling

60 bipolar disorder overview signs & symptoms differential diagnosis Mood-stabilizers Atypical antipsychotics Lithium Certain anticonvulsants (valproate, carbamezapine, oxycarbamezapine, lamotrigine) diagnosis management pearls & pitfalls

61 bipolar disorder overview signs & symptoms differential diagnosis diagnosis management pearls & pitfalls Pediatric mania is More irritability than euphoria More mixed states and complex cycling More chronic More co-morbidities Parenting does not cause BPD Parents may see it first Antidepressants, stimulants can exacerbate mania

62 stimulants Generic methylphenidate dexmethylphenidate Brand Ritalin, Ritalin SR, Ritalin LA Metadate CD, Metadate ER Methylin, Methylin ER Concerta, Daytrana Focalin, Focalin XR dextroamphetamine Dextrostat, Dexedrine, Dexedrine spansules amphetamine salts Adderall, Adderall XR

63 2 adrenergic agonists Generic Brand clonidine Catapres, Kapvay guanfacine Tenex, Intuniv noradrenergic reuptake inhibitpr Generic Brand atomoxetine Strattera

64 SSRI antidepressants Generic Brand T 1/2 Steady state fluoxetine Prozac hrs 5 weeks paroxetine Paxil 21 hrs 7-10 days sertraline Zoloft 26 hrs 7-10 days fluvoxamine Luvox 16 hrs 7-10 days citalopram Celexa 36 hrs 7-10 days escitalopram Lexapro hrs 7-10 days SSRI = selective serotonin reuptake inhibitor

65 atypical antidepressants Generic Brand buspirone Buspar clomipramine Anafranil bupropion Wellbutrin, Wellbutrin XR mirtazapine Remeron venlafaxine Effexor, Effexor XR imiprimine Tofranil nortriptyline Pamelor nefazodone Serzone trazodone Desyrel

66 atypical neuroleptics Generic Brand risperdone (H) Risperdal olanzepine (M) Zyprexa quetiapine (M) Seroquel aripiprazole (L) Abilify ziprasidone (M) Geodon clozapine (L) Clozaril L=low potency; M = medium or intermediate potency; H=high potency

67 antiepileptic & mood stabilizers Generic Brand lithium carbonate Lithobid carbamazepine Tegretol oxcarbazepine Trileptal valproate Depakote lamotrigine Lamictal gabapentin Neurontin topiramate Tpopmax clonazepam Klonopin

68 final comments Your role is helping decide typical from atypical. There are tools available to you. Make the diagnosis. Manage the condition.

Judges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children

Judges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children Judges Reference Table for the Psychotropic Medication Utilization Parameters for Foster Children Stimulants for treatment of ADHD Preschool (Ages 3-5 years) Child (Ages 6-12 years) Adolescent (Ages 13-17

More information

Medications and Children Disorders

Medications and Children Disorders Mental Health Comprehensive Services Providing Family Stability and Developing Life Coping Skills Medications and Children Disorders Psychiatric medications can be an effective part of the treatment for

More information

Psychiatric Medications. Positive and negative effects in the classroom

Psychiatric Medications. Positive and negative effects in the classroom Psychiatric Medications Positive and negative effects in the classroom Teaching the Medicated Child Beverly Bryant, M.D. Hattiesburg Clinic 9/17/14 Introduction According to the National Survey of Children

More information

Guide to Psychiatric Medications for Children and Adolescents

Guide to Psychiatric Medications for Children and Adolescents Guide to Psychiatric Medications for Children and Adolescents by Glenn S. Hirsch, M.D. The following guide includes most of the medications used to treat child and adolescent mental disorders. It lists

More information

Review of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course)

Review of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course) Review of Psychotrophic Medications (An approved North Carolina Division of Health Services Regulation Continuing Education Course) Common Psychiatric Disorders *Schizophrenia *Depression *Bipolar Disorder

More information

Schedule FDA & literature based indications

Schedule FDA & literature based indications Psychotropic Medication List Recommended dosages are intended to serve only as a guide for children. Recommended doses are literature based. Clinicians should consult package insert of medications for

More information

PSYCHIATRY INTAKE FORM

PSYCHIATRY INTAKE FORM Please complete all information on this form. PSYCHIATRY INTAKE FORM Name Date Date of Birth Primary Care Physician Current Therapist/Counselor What are the problem(s) for which you are seeking help? 1.

More information

4/2/13 COMMON CLASSES OF MEDICATIONS. Child & Adolescent Behavioral Medicine & Medication Therapies. Behavioral Medicine & Medication Therapies

4/2/13 COMMON CLASSES OF MEDICATIONS. Child & Adolescent Behavioral Medicine & Medication Therapies. Behavioral Medicine & Medication Therapies Child & Adolescent Behavioral Medicine & Medication Therapies Brian J Cowles, PharmD Associate Professor of Pharmacy Practice Albany College of Pharmacy & Health Sciences; Vermont Campus Behavioral Medicine

More information

Child & Adolescent Psychiatry (a brief overview)

Child & Adolescent Psychiatry (a brief overview) Child & Adolescent Psychiatry (a brief overview) Lance Feldman, MD, FAPA, MBA, BSN Vice Chair Clinical Affairs, Department of Psychiatry Affiliate Clinical Assistant Professor, University of South Carolina

More information

Richard Heidenfelder M.D. Child, Adolescent and Adult Psychiatry 447 9th Ave San Diego, CA

Richard Heidenfelder M.D. Child, Adolescent and Adult Psychiatry 447 9th Ave San Diego, CA *We are not accepting any New Patients who are currently taking any controlled pain medications *We are *Note: not completion accepting of the any following New Patients paperwork who and Initial are Screening

More information

A Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer

A Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer A Brief Overview of Psychiatric Pharmacotherapy Joel V. Oberstar, M.D. Chief Executive Officer Disclosures Some medications discussed are not approved by the FDA for use in the population discussed/described.

More information

Mental Health Nursing: Mood Disorders. By Mary B. Knutson, RN, MS, FCP

Mental Health Nursing: Mood Disorders. By Mary B. Knutson, RN, MS, FCP Mental Health Nursing: Mood Disorders By Mary B. Knutson, RN, MS, FCP A Definition of Mood Prolonged emotional state that influences the person s whole personality and life functioning Adaptive Functions

More information

TRANSCRANIAL MAGNETIC STIMULATION & BRAIN MUSIC THERAPY

TRANSCRANIAL MAGNETIC STIMULATION & BRAIN MUSIC THERAPY TMS - DEPRESSION HISTORY Date: Patient Name: DOB: How did you hear about TMS? What do you know about TMS? Referring Physician? Name of Practice: Name of Inpatient Treatment for Depression: Name of Inpatient

More information

Creating Partnerships. Laine Young-Walker, MD

Creating Partnerships. Laine Young-Walker, MD Creating Partnerships Laine Young-Walker, MD Psychiatry is the medical specialty devoted to the study, diagnosis, treatment and prevention of mental disorders. Medical school >>>four years of residency

More information

IMPORTANT NOTICE. Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members

IMPORTANT NOTICE. Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members IMPORTANT NOTICE Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members These changes apply only to members covered under the DC Healthcare Alliance program Alliance

More information

Mental Health Intake Form

Mental Health Intake Form Current Symptoms Checklist: (check once for any symptoms present, twice for major symptoms) ( ) ( ) Depressed mood ( ) ( ) Racing thoughts ( ) ( ) Excessive worry ( ) ( ) Unable to enjoy activities ( )

More information

Medically Accepted Indications for Pediatric Use of Psychotropic Medications by

Medically Accepted Indications for Pediatric Use of Psychotropic Medications by Key: White Background: Medically Accepted Indication Yellow Backgroun: Medically Accepted Indication Status Not Ascertained Orange Background: Pediatric Indication cited, but not supported Red Background:

More information

Mental Illness. Doreen L. Rasp, APN, FNP, PMHNP Advanced Behavioral Counseling

Mental Illness. Doreen L. Rasp, APN, FNP, PMHNP Advanced Behavioral Counseling Mental Illness Doreen L. Rasp, APN, FNP, PMHNP Advanced Behavioral Counseling Moodiness Changing Bodies Narcissism Self-Esteem Ignorant Naïve Insecure Self-Centered Independent Adolescence Disorders Affecting

More information

Change Your Brain, Change Your Life. The Breakthrough Program for Conquering Anxiety, Depression, Obsessiveness, Anger, and Impulsiveness

Change Your Brain, Change Your Life. The Breakthrough Program for Conquering Anxiety, Depression, Obsessiveness, Anger, and Impulsiveness Change Your Brain, Change Your Life The Breakthrough Program for Conquering Anxiety, Depression, Obsessiveness, Anger, and Impulsiveness Daniel G Amen Three Rivers Press New York Appendix Medication 1.

More information

Happy Daisy Ltd. New Client intake Form. What are the issues for which you are seeking care?

Happy Daisy Ltd. New Client intake Form. What are the issues for which you are seeking care? Happy Daisy Ltd. New Client intake Form Name Date Preferred name Pronouns Referred by Date of birth Age Race What are the issues for which you are seeking care? 1. 2. 3. Please check of any of the symptoms

More information

Mental Health Intake Form

Mental Health Intake Form 38600 Van Dyke Ave., Suite 200 Sterling Heights, MI 48313 Phone: (586) 933-5395 Fax: (586) 935-0159 Mental Health Intake Form Please complete all information on this form and bring it to the first visit.

More information

The Benefits and Limitations of Medication Treatment for Executive Dysfunctions and ADHD

The Benefits and Limitations of Medication Treatment for Executive Dysfunctions and ADHD The Benefits and Limitations of Medication Treatment for Executive Dysfunctions and ADHD Damon Korb, MD Behavioral and Developmental Pediatrician Director of the Center for Developing Minds Los Gatos,

More information

Managing the Behavior Problems of Children With Fragile X Syndrome by Using Medication Ave M. Lachiewicz, MD, Duke University Medical Center

Managing the Behavior Problems of Children With Fragile X Syndrome by Using Medication Ave M. Lachiewicz, MD, Duke University Medical Center Managing the Behavior Problems of Children With Fragile X Syndrome by Using Medication Ave M. Lachiewicz, MD, Duke University Medical Center Abstract: The majority of boys and many girls with fragile X

More information

Depression. University of Illinois at Chicago College of Nursing

Depression. University of Illinois at Chicago College of Nursing Depression University of Illinois at Chicago College of Nursing 1 Learning Objectives Upon completion of this session, participants will be better able to: 1. Recognize depression, its symptoms and behaviors

More information

New Patient Questionnaire

New Patient Questionnaire 4 Embarcadero Center, Suite 1400, San Francisco, CA 94111 (415) 926-7774 phone; (415) 591-7760 office@sanfranciscopsych.com New Patient Questionnaire Thank you for trusting San Francisco Psychiatry with

More information

Autism: Improving Health Care Outcomes

Autism: Improving Health Care Outcomes AUTISM AWARESS CONFERENCE Lewis County Autism Coalition 23 September 2011 Autism: Improving Health Care Outcomes Glenn C. Tripp, M.D. Developmental Behavioral Pediatrics Medical Director, Developmental

More information

Medications for Anxiety & Behavior in Williams Syndrome. Disclosure of Potential Conflicts. None 9/22/2016. Evaluation

Medications for Anxiety & Behavior in Williams Syndrome. Disclosure of Potential Conflicts. None 9/22/2016. Evaluation Medications for Anxiety & Behavior in Williams Syndrome Christopher J. McDougle, M.D. Director, Lurie Center for Autism Professor of Psychiatry and Pediatrics Massachusetts General Hospital and MassGeneral

More information

6/22/2012. Co-morbidity - when two or more conditions occur together. The two conditions may or may not be causally related.

6/22/2012. Co-morbidity - when two or more conditions occur together. The two conditions may or may not be causally related. Autism Spectrum Disorders and Co-existing Mental Health Issues By Dr. Karen Berkman Objective To present an overview of common psychiatric conditions that occur in persons with autism spectrum disorders

More information

AD/HD is a mental disorder, and it often lasts from

AD/HD is a mental disorder, and it often lasts from short version10 WHAT WE KNOW Managing Medication for Adults with AD/HD AD/HD is a mental disorder, and it often lasts from childhood into adulthood. Medication is the basic part of treatment for adults.

More information

CHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XV, 2013 INDEX

CHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XV, 2013 INDEX A acceptance and commitment therapy Posttraumatic Stress, 69 ADHD Adjunctive Fatty Acids, 5 Adjunctive Guanfacine Pharmacokinetics, 27 Amantadine, 21 Atomoxetine, 23 Cancer Risk, 31 CBT for Comorbid Anxiety,

More information

Index. Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) b-adrenergic blockers

Index. Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) b-adrenergic blockers Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) a-adrenergic blockers for PTSD, 798 b-adrenergic blockers for PTSD, 798 Adrenergic

More information

Are All Older Adults Depressed? Common Mental Health Disorders in Older Adults

Are All Older Adults Depressed? Common Mental Health Disorders in Older Adults Are All Older Adults Depressed? Common Mental Health Disorders in Older Adults Cherie Simpson, PhD, APRN, CNS-BC Myth vs Fact All old people get depressed. Depression in late life is more enduring and

More information

Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials

Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials SPEAKER NOTES Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials Summarized by Thomas T. Thomas New psychotropic medications are coming on the

More information

The Mental Health and Wellbeing of Children and Adolescents who are affected by Autism and Related Disorders

The Mental Health and Wellbeing of Children and Adolescents who are affected by Autism and Related Disorders The Mental Health and Wellbeing of Children and Adolescents who are affected by Autism and Related Disorders Charles Cartwright, M.D Director: YAI Autism Center March 2013 Autism Spectrum Defined by the

More information

3/19/2018. Cynthia King, MD Associate Professor of Psychiatry UNMSOM. Autism Spectrum Disorder

3/19/2018. Cynthia King, MD Associate Professor of Psychiatry UNMSOM. Autism Spectrum Disorder Cynthia King, MD Associate Professor of Psychiatry UNMSOM Autism Spectrum Disorder 1 Identify three behavioral health concerns in ASD Identify three common families of medication that may be supportive

More information

3/19/2018. Cynthia King, MD Associate Professor of Psychiatry UNMSOM

3/19/2018. Cynthia King, MD Associate Professor of Psychiatry UNMSOM Cynthia King, MD Associate Professor of Psychiatry UNMSOM 1 2 Autism Spectrum Disorder 3 Identify three behavioral health concerns in ASD Identify three common families of medication that may be supportive

More information

Study Guidelines for Quiz #1

Study Guidelines for Quiz #1 Annex to Section J Page 1 Study Guidelines for Quiz #1 Theory and Principles of Psychopharmacology, Classifications and Neurotransmitters, Anxiolytics/Antianxiety/Minor Tranquilizers, Stimulants, Nursing

More information

Pediatric Psychopharmacology

Pediatric Psychopharmacology Pediatric Psychopharmacology General issues to consider. Pharmacokinetic differences Availability of Clinical Data Psychiatric Disorders can be common in childhood. Early intervention may prevent disorders

More information

Dealing with a Mental Health Crisis

Dealing with a Mental Health Crisis Dealing with a Mental Health Crisis Information and Resources for First Responders P... PROFESSIONAL WHAT NAMI DOES NAMI Minnesota is a statewide 501(c)(3) grassroots nonprofit organization dedicated to

More information

The Use of ADHD Medication in the Pediatric Population

The Use of ADHD Medication in the Pediatric Population The Use of ADHD Medication in the Pediatric Population Shirin Madzhidova, PharmD Pediatric Pharmacotherapy Fellow Nova Southeastern University Objectives Discuss the importance of treatment with medications

More information

Attention Deficit Hyperactivity Disorder (ADHD) in Children under Age 6

Attention Deficit Hyperactivity Disorder (ADHD) in Children under Age 6 in Children under Age 6 Level 0 Conduct comprehensive assessment and provide psychoeducation about ADHD, including clearly defined treatment expectations. Consider co-morbid developmental language disorder,

More information

Brief Notes on the Mental Health of Children and Adolescents

Brief Notes on the Mental Health of Children and Adolescents Brief Notes on the Mental Health of Children and Adolescents The future of our country depends on the mental health and strength of our young people. However, many children have mental health problems

More information

ADHD and. Shaw Wendi Fortuchang, M.D. Board certified in Child & Adolescent, Adult, and Forensic Psychiatry

ADHD and. Shaw Wendi Fortuchang, M.D. Board certified in Child & Adolescent, Adult, and Forensic Psychiatry ADHD and Beyond Shaw Wendi Fortuchang, M.D. Board certified in Child & Adolescent, Adult, and Forensic Psychiatry Overview Use of medications in children How do medications work in the brain? Risperdal?

More information

Medications in Autism: What We Know and Don't Know

Medications in Autism: What We Know and Don't Know Medications in Autism: What We Know and Don't Know Jeremy Veenstra-VanderWeele, M.D. Mortimer D. Sackler, M.D., Associate Professor Center for Autism and the Developing Brain Sackler Institute for Developmental

More information

CHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XIV, 2012 INDEX

CHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XIV, 2012 INDEX A Adderall Counterfeit, 31 addiction, internet CBT, 55 ADHD Adjunctive Guanfacine, 11 Counterfeit Adderall, 31 Developmental Trajectory and Risk Factors, 5 Dopamine Transporter Alterations, 14 Extended-Release

More information

FROM MEDICATION TO MINDFULNESS: NEW INSIGHTS INTO THE WORLD OF ANXIETY

FROM MEDICATION TO MINDFULNESS: NEW INSIGHTS INTO THE WORLD OF ANXIETY 13 th Pearl Leibovitch Clinical Day November 18th, 2014 Mounir H. Samy, MD, FRCP(C) Associate Professor of Psychiatry McGill University (ret.) FROM MEDICATION TO MINDFULNESS: NEW INSIGHTS INTO THE WORLD

More information

Appendix: Psychotropic Medication Reference Tables

Appendix: Psychotropic Medication Reference Tables Appendix: Psychotropic Medication Reference Tables How to Use these Tables These reference tables are designed to provide clinic staff with specific medication related criteria for the Polypharmacy, Cardiometabolic

More information

Behavioral Health. Behavioral Health. Prescribing Guidelines

Behavioral Health. Behavioral Health. Prescribing Guidelines Behavioral Health Behavioral Health Prescribing Guidelines Attention Deficit/Hyperactivity Disorder (ADHD) Start with a first line medication, either from the methylphenidate or dextroamphetamine-amphetamine

More information

Adult Initial Assessment / Patient Questionnaire Page 1

Adult Initial Assessment / Patient Questionnaire Page 1 Page 1 Patient Name: Date: Age: Date of Birth: / / Please read the following questions and answer to the best of your ability by placing a checkmark in the appropriate boxes or filling in the blank as

More information

Management Of Depression And Anxiety

Management Of Depression And Anxiety Management Of Depression And Anxiety CME Financial Disclosure Statement I, or an immediate family member including spouse/partner, have at present and/or have had within the last 12 months, or anticipate

More information

We ll Be Discussing. Pregnancy 4/24/2013

We ll Be Discussing. Pregnancy 4/24/2013 Joe Wegmann, PD, LCSW The PharmaTherapist Joe@ThePharmaTherapist.com 504.587.9798 www.pharmatherapist.com Are you receiving our free monthly e-newsletter? We ll Be Discussing The safety and efficacy track

More information

Treat mood, cognition, and behavioral disturbances associated with psychological disorders. Most are not used recreationally or abused

Treat mood, cognition, and behavioral disturbances associated with psychological disorders. Most are not used recreationally or abused Psychiatric Drugs Psychiatric Drugs Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally or abused Benzodiazepines

More information

PSYCHIATRIC DRUGS. Mr. D.Raju, M.pharm, Lecturer

PSYCHIATRIC DRUGS. Mr. D.Raju, M.pharm, Lecturer PSYCHIATRIC DRUGS Mr. D.Raju, M.pharm, Lecturer PSYCHIATRIC DRUGS Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally

More information

Treating Disruptive Behavior Disorders in Children and Teens. A Review of the Research for Parents and Caregivers

Treating Disruptive Behavior Disorders in Children and Teens. A Review of the Research for Parents and Caregivers Treating Disruptive Behavior Disorders in Children and Teens A Review of the Research for Parents and Caregivers e Is This Information Right for Me? This information is for you if: A health care professional*

More information

Mood Disorders for Care Coordinators

Mood Disorders for Care Coordinators Mood Disorders for Care Coordinators David A Harrison, MD, PhD Assistant Professor, Dept of Psychiatry & Behavioral Sciences University of Washington School of Medicine Introduction 1 of 3 Mood disorders

More information

Welcome and thank you for choosing University of Florida Physicians!

Welcome and thank you for choosing University of Florida Physicians! DEPARTMENT OF PSYCHIATRY Tuesday, Division of March Child and 14, Adolescent 2017 Psychiatry 8491 NW 39 th Ave. Gainesville, FL 32606 Phone: 352-265-4357 Fax: 352-627-4163 Welcome and thank you for choosing

More information

Depression & Anxiety in Adolescents

Depression & Anxiety in Adolescents Depression & Anxiety in Adolescents Objectives 1) Review diagnosis of anxiety and depression in adolescents 2) Provide overview of evidence-based treatment options 3) Increase provider comfort level with

More information

ADHD Medications Table

ADHD Medications Table Stimulants are the first line treatment of choice for ADHD followed by Non-Stimulants, then off-label medications. We are providing this list of medications so that you can be familiar with the common

More information

Psychotropic Medications in Children and Adolescents: Guide for Use and Monitoring

Psychotropic Medications in Children and Adolescents: Guide for Use and Monitoring Psychotropic Medications in Children and Adolescents: Guide for Use and This document was developed by Community Care of North Carolina with the assistance of the Medication Management Workgroup of the

More information

Prepared by: Elizabeth Vicens-Fernandez, LMHC, Ph.D.

Prepared by: Elizabeth Vicens-Fernandez, LMHC, Ph.D. Prepared by: Elizabeth Vicens-Fernandez, LMHC, Ph.D. Sources: National Institute of Mental Health (NIMH), the National Alliance on Mental Illness (NAMI), and from the American Psychological Association

More information

Pediatric Primary Care Mental Health Specialist Certification Exam. Detailed Content Outline

Pediatric Primary Care Mental Health Specialist Certification Exam. Detailed Content Outline Pediatric Primary Care Mental Health Specialist Certification Exam Detailed Content Outline Description of the Specialty The Pediatric Primary Care Mental Health Specialist (PMHS) builds upon the Advanced

More information

USF Health Psychiatry Clinic. New Patient Questionnaire Adult

USF Health Psychiatry Clinic. New Patient Questionnaire Adult USF Health Psychiatry Clinic New Patient Questionnaire Adult Please mail or fax the completed forms to the address/fax number on the bottom of this page. Completed forms must be received five (5) days

More information

Treatment of Children with Mental Disorders

Treatment of Children with Mental Disorders Treatment of Children with Mental Disorders Children are in a state of rapid change and growth during their developmental years. Diagnosis and treatment of mental disorders must be viewed with these changes

More information

Ohio Psychotropic Medication Quality Improvement Collaborative. Minds Matter. Toolkit. for You and Your Family. This is the property of

Ohio Psychotropic Medication Quality Improvement Collaborative. Minds Matter. Toolkit. for You and Your Family. This is the property of Minds Matter Ohio Psychotropic Medication Quality Improvement Collaborative Minds Matter Toolkit for You and Your Family This is the property of About Minds Matter Minds Matter is a project to help teens,

More information

Explosive Youth: Common Brain Disorders. Juvenile Law Conference 2005 Larry Fisher, Ph.D. UHS Neurobehavioral Systems

Explosive Youth: Common Brain Disorders. Juvenile Law Conference 2005 Larry Fisher, Ph.D. UHS Neurobehavioral Systems Explosive Youth: Common Brain Disorders Juvenile Law Conference 2005 Larry Fisher, Ph.D. UHS Neurobehavioral Systems For More Information Larry Fisher, Ph.D. Director of Neuropsychological Services UHS

More information

Medications, By Class, in TBI

Medications, By Class, in TBI Medications, By Class, in TBI Generic/Brand Name Drawback Advantage Mood Stabilizers (anti-seizure medications) Carbamazepine (Carbatrol ) (Equetro ) (Tegretol ) Gabapentin (Neurontin ) Lamotrigine (Lamictal

More information

7/9/2013. Psychiatric medication treatment in children and adolescents: The good, the bad and the ugly. What ADHD is

7/9/2013. Psychiatric medication treatment in children and adolescents: The good, the bad and the ugly. What ADHD is Psychiatric medication treatment in children and adolescents: The good, the bad and the ugly Gabrielle A. Carlson, MD Professor of Psychiatry and Pediatrics Director, Child and Adolescent Psychiatry Stony

More information

Practice Parameter for the Assessment and Treatment of Children and Adolescents with Bipolar Disorder,

Practice Parameter for the Assessment and Treatment of Children and Adolescents with Bipolar Disorder, Practice Parameter for the Assessment and Treatment of Children and Adolescents with Bipolar Disorder, Journal of the Academy of Child and Adolescent Psychiatry, 1997 Primary Authors: Jon McClellan MD

More information

John E. Kraus, M.D., Ph.D.

John E. Kraus, M.D., Ph.D. John E. Kraus, M.D., Ph.D. Chief, Adult Psychiatry, Dorothea Dix Hospital, Raleigh, NC Assistant Professor/Associate Director of Residency Training, Dept. of Psychiatry, UNC Hospitals, Chapel Hill, NC

More information

DEPRESSION. Men and women of all ages, races, and economic levels can have depression. It occurs more often in women.

DEPRESSION. Men and women of all ages, races, and economic levels can have depression. It occurs more often in women. DEPRESSION The exact cause of depression is not known. Many researchers believe it is caused by chemical imbalances in the brain, which may be hereditary or caused by events in a person's life. Some types

More information

Tourette Syndrome. Biological Basis, Clinical Symptoms, Treatment. Drake D. Duane, MS, MD

Tourette Syndrome. Biological Basis, Clinical Symptoms, Treatment. Drake D. Duane, MS, MD Tourette Syndrome Biological Basis, Clinical Symptoms, Treatment Drake D. Duane, MS, MD Director, Institute for Developmental Behavioral Neurology Adjunct Professor, Arizona State University Scottsdale/Tempe,

More information

Psychiatric Illness. In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis

Psychiatric Illness. In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis Psychiatric Illness In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis 12,000,000 children infants through 18 y/o nation wide 5,000,000 suffer severely Serious

More information

ASD Autism Spectrum Disorder

ASD Autism Spectrum Disorder Psychopharmacology and Autism Spectrum Disorder Bennett L. Leventhal, MD Professor Department of Psychiatry University of California, San Francisco Sources of Research Support NIH Simons Foundation Janssen

More information

Antidepressant Medication Strategies We ve Come a Long Way or Have We? Who Writes Prescriptions for Psychotropic Medications. Biological Psychiatry

Antidepressant Medication Strategies We ve Come a Long Way or Have We? Who Writes Prescriptions for Psychotropic Medications. Biological Psychiatry Antidepressant Medication Strategies We ve Come a Long Way or Have We? Joe Wegmann, PD, LCSW The PharmaTherapist Joe@ThePharmaTherapist.com 504.587.9798 www.pharmatherapist.com Are you receiving our free

More information

Humberto Nagera M.D. Director, The Carter-Jenkins Center Psychoanalyst, Children, Adolescents and Adults Professor of Psychiatry at USF Professor

Humberto Nagera M.D. Director, The Carter-Jenkins Center Psychoanalyst, Children, Adolescents and Adults Professor of Psychiatry at USF Professor The Carter Jenkins Center presents 1 Humberto Nagera M.D. Director, The Carter-Jenkins Center Psychoanalyst, Children, Adolescents and Adults Professor of Psychiatry at USF Professor Emeritus of Psychiatry

More information

AAA. add dan campbell artwork cats? Report #12 Changes in Medication Use over Time in Adolescents and Adults with Autism Spectrum Disorders

AAA. add dan campbell artwork cats? Report #12 Changes in Medication Use over Time in Adolescents and Adults with Autism Spectrum Disorders AAA Adolescents & Adults with Autism A Study of Family Caregiving add dan campbell artwork cats? Report #12 Changes in Medication Use over Time in Adolescents and Adults with Autism Spectrum Disorders

More information

Steps for Initiating Electroconvulsive Therapy Treatment

Steps for Initiating Electroconvulsive Therapy Treatment Steps for Initiating Electroconvulsive Therapy Treatment PSYCHIATRISTS CAN REFER PATIENTS FOR ECT TREATMENT AT EL CAMINO HOSPITAL BY CALLING THE ECT NURSE COORDINATOR AT 650-962-5795. Once the referral

More information

5/2/2017. By Pamela Pepper PMH, CNS, BC. DSM-5 Growth and Development

5/2/2017. By Pamela Pepper PMH, CNS, BC. DSM-5 Growth and Development By Pamela Pepper PMH, CNS, BC DSM-5 Growth and Development The idea that diagnosis is based on subjective criteria and that those criteria should fall neatly into a set of categories is not sustainable,

More information

Where to from Here? Evidence-Based Strategies for Treatment of Refractory Depression

Where to from Here? Evidence-Based Strategies for Treatment of Refractory Depression Where to from Here? Evidence-Based Strategies for Treatment of Refractory Depression Michael D. Jibson, MD, PhD Professor of Psychiatry University of Michigan Major Depression #1 WHO cause of disability

More information

Partners in Care Quick Reference Cards

Partners in Care Quick Reference Cards Partners in Care Quick Reference Cards Supported by the Agency for Healthcare Research and Quality MR-1198/8-AHRQ R This project was funded by the Agency for Healthcare Research and Quality (AHRQ), formerly

More information

Mental Health Medications. National Institute of Mental Health. U.S. Department of HealtH and HUman ServiceS National Institutes of Health

Mental Health Medications. National Institute of Mental Health. U.S. Department of HealtH and HUman ServiceS National Institutes of Health Mental Health Medications National Institute of Mental Health U.S. Department of HealtH and HUman ServiceS National Institutes of Health Contents Mental Health Medications...1 What are psychiatric medications?...1

More information

Adult Depression - Clinical Practice Guideline

Adult Depression - Clinical Practice Guideline 1 Adult Depression - Clinical Practice Guideline 05/2018 Diagnosis and Screening Diagnostic criteria o Please refer to Attachment A Screening o The United States Preventative Services Task Force (USPSTF)

More information

NorthSTAR. Pharmacy Manual

NorthSTAR. Pharmacy Manual NorthSTAR Pharmacy Manual Revised October, 2008 Table of I. Introduction II. III. IV. Antidepressants New Generation Antipsychotic Medications Mood Stabilizers V. ADHD Medications VI. Anxiolytics and Sedative-Hypnotics

More information

Practical Psychopharmacology for More Complex Mental Health Presentations

Practical Psychopharmacology for More Complex Mental Health Presentations MINISTRY OF CHILDREN AND YOUTH SERVICES Practical Psychopharmacology for More Complex Mental Health Presentations Part 1: Stimulants Dr. Ajit Ninan & Joel Lamoure 1 Practical Psychopharmacology for More

More information

Evidence-Based Pharmacotherapy. Emily Harris, MD, MPH, FAAP Cincinnati Children s Hospital Medical Center

Evidence-Based Pharmacotherapy. Emily Harris, MD, MPH, FAAP Cincinnati Children s Hospital Medical Center Evidence-Based Pharmacotherapy Emily Harris, MD, MPH, FAAP Cincinnati Children s Hospital Medical Center CME Disclosure I have no personal financial relationships in any commercial interest related to

More information

Ask The Shrink: ADHD

Ask The Shrink: ADHD Ask The Shrink: ADHD Theodore A. Petti, MD Professor of Psychiatry Division of Child and Adolescent Psychiatry Robert Wood Johnson Medical School PPC Hub Psychiatrist Hackensack Meridian Hubs @ Saint Peter'

More information

Psychopharmacology for Treatment of ADHD and ADHD with other co-existing psychiatric condition

Psychopharmacology for Treatment of ADHD and ADHD with other co-existing psychiatric condition Psychopharmacology for Treatment of ADHD and ADHD with other co-existing psychiatric condition Presented by Cat Dang, D.O Medical Director - Insightful Minds, Inc. Objectives Evaluation process Pharmacology

More information

Psychopharmacology: An Overview

Psychopharmacology: An Overview Psychopharmacology: An Overview John Tanquary, M.D. Clinical Assistant Professor Department of Psychiatry Upstate Medical University Psychpharmacology Consultant Le Moyne College Syracuse University Financial

More information

Depression and Anxiety. What is Depression? What is Depression? By Christopher Okiishi, MD Spring Not just being sad A syndrome of symptoms

Depression and Anxiety. What is Depression? What is Depression? By Christopher Okiishi, MD Spring Not just being sad A syndrome of symptoms Depression and Anxiety By Christopher Okiishi, MD Spring 2016 What is Depression? Not just being sad A syndrome of symptoms Depressed mood Sleep disturbance Decreased interest in usual activities (anhedonia)

More information

Depression major depressive disorder. Some terms: Major Depressive Disorder: Major Depressive Disorder:

Depression major depressive disorder. Some terms: Major Depressive Disorder: Major Depressive Disorder: Depression major depressive disorder Oldest recognized disorder: melancholia It is a positive and active anguish, a sort of psychical neuralgia wholly unknown to normal life. - William James "I am now

More information

Psychiatric medication treatment in children and adolescents:

Psychiatric medication treatment in children and adolescents: Psychiatric medication treatment in children and adolescents: The good, the bad and the ugly Gabrielle A. Carlson, MD Professor of Psychiatry and Pediatrics Director, Child and Adolescent Psychiatry Stony

More information

Psychobiology Handout

Psychobiology Handout Nsg 85A / Psychiatric Page 1 of 7 Psychobiology Handout STRUCTURE AND FUNCTION OF THE BRAIN Psychiatric illness and the treatment of psychiatric illness alter brain functioning. Some examples of this are

More information

Big Lots Behavioral Health. Prescribing Guidelines for Behavioral Health

Big Lots Behavioral Health. Prescribing Guidelines for Behavioral Health Big Lots Behavioral Health Prescribing Guidelines for Behavioral Health Prescribing for Behavioral Health This document was developed by Nationwide Children s Hospital in conjunction with Partners For

More information

Pediatric Psychopharmacology: Erika Ryst, M.D. October 12, 2016

Pediatric Psychopharmacology: Erika Ryst, M.D. October 12, 2016 Pediatric Psychopharmacology: Erika Ryst, M.D. October 12, 2016 Good psychopharmacology depends on Proper use of safe and effective meds Treatment of other obvious factors (e.g., medical conditions, toxic

More information

Drugs for Emotional and Mood Disorders Chapter 16

Drugs for Emotional and Mood Disorders Chapter 16 Drugs for Emotional and Mood Disorders Chapter 16 NCLEX-RN Review Question 1 Choices Please note Question #1 at the end of Ch 16 pg 202 & Key pg 805 answer is #4 1. Psychomotor symptoms 2. Tachycardia,

More information

2013 Virtual AD/HD Conference 1

2013 Virtual AD/HD Conference 1 Medication for & Coexisting Conditions Part 2 Dr. Kenny Handelman Child, Adolescent & Adult Psychiatrist Halton Healthcare Adjunct Professor of Psychiatry, University of Western Ontario www.drkenny.com

More information

Introductory discussion

Introductory discussion Billina R. Shaw, MD Assistant Professor University of Maryland School of Medicine Department of Psychiatry Division of Child and Adolescent Psychiatry Introductory discussion Prescribing trends in foster

More information

Psychiatric Issues in Huntington s Disease

Psychiatric Issues in Huntington s Disease Psychiatric Issues in Huntington s Disease Arik Johnson, PsyD HDSA Center of Excellence at UCLA June 24, 2011 26th Annual HDSA Conference Minneapolis, MN The information provided by speakers in workshops,

More information